69 related articles for article (PubMed ID: 21811057)
1. Cytogenetic analysis of CpG-oligonucleotide DSP30 plus Interleukin-2-Stimulated canine B-Cell lymphoma cells reveals the loss of one X Chromosome as the sole abnormality.
Reimann-Berg N; Murua Escobar H; Kiefer Y; Mischke R; Willenbrock S; Eberle N; Nolte I; Bullerdiek J
Cytogenet Genome Res; 2011; 135(1):79-82. PubMed ID: 21811057
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.
Struski S; Gervais C; Helias C; Herbrecht R; Audhuy B; Mauvieux L
Leukemia; 2009 Mar; 23(3):617-9. PubMed ID: 18830262
[No Abstract] [Full Text] [Related]
3. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L;
Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829
[TBL] [Abstract][Full Text] [Related]
4. Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation.
Shi M; Cipollini MJ; Crowley-Bish PA; Higgins AW; Yu H; Miron PM
Am J Clin Pathol; 2013 May; 139(5):662-9. PubMed ID: 23596118
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Holmes PJ; Peiper SC; Uppal GK; Gong JZ; Wang ZX; Bajaj R
Int J Lab Hematol; 2016 Oct; 38(5):483-9. PubMed ID: 27565124
[TBL] [Abstract][Full Text] [Related]
6. Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma.
Devitt JJ; Maranon DG; Ehrhart EJ; Bachand AM; Lana SE; LaRue SM
Cytogenet Genome Res; 2009; 124(1):12-8. PubMed ID: 19372664
[TBL] [Abstract][Full Text] [Related]
7. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
[TBL] [Abstract][Full Text] [Related]
8. Chromosome analyses in dogs.
Reimann-Berg N; Bullerdiek J; Murua Escobar H; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):191-6. PubMed ID: 22688796
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic findings in reactive lymphoid hyperplasia: significance of non-clonal t(3;14) and t(3;22).
Au WY; Horsman DE; Connors JM; Klasa RJ; Gascoyne RD
Am J Hematol; 2002 Jun; 70(2):133-8. PubMed ID: 12111786
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic investigations of chronic lymphocytic leukemia.
Wren C; Moriarty H; Marsden K; Tegg E
Cancer Genet Cytogenet; 2010 Apr; 198(2):155-61. PubMed ID: 20362231
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic investigations in four canine lymphomas.
Winkler S; Murua Escobar H; Reimann-Berg N; Bullerdiek J; Nolte I
Anticancer Res; 2005; 25(6B):3995-8. PubMed ID: 16309190
[TBL] [Abstract][Full Text] [Related]
12. CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL).
Liaw FP; Lau LC; Lim AS; Lim TH; Lee GY; Tien SL
Int J Hematol; 2014 Dec; 100(6):545-53. PubMed ID: 25301672
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic analysis of three oropharyngeal malignant melanomas in dogs.
Hörsting N; Wohlsein P; Reimann N; Bartnitzke S; Bullerdiek J; Nolte I
Res Vet Sci; 1999 Oct; 67(2):149-51. PubMed ID: 10502484
[TBL] [Abstract][Full Text] [Related]
14. Other lymphoid malignancies: cytogenetic techniques.
Swansbury J
Methods Mol Biol; 2003; 220():111-23. PubMed ID: 12744210
[No Abstract] [Full Text] [Related]
15. DSP30 and interleukin-2 as a mitotic stimulant in B-cell disorders including those with a low disease burden.
Dun KA; Riley LA; Diano G; Adams LB; Chiu E; Sharma A
Genes Chromosomes Cancer; 2018 May; 57(5):260-267. PubMed ID: 29349871
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
Ponzio NM; Cutro S; Hu J; Marzouk A; Marshall JD
Int Immunopharmacol; 2006 Dec; 6(13-14):2057-68. PubMed ID: 17161362
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma.
Dutta SK; Novilla MN; Bumgardner MK; Ingling A
Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738
[TBL] [Abstract][Full Text] [Related]
18. Recurrent chromosomal abnormalities in lymphomas in fine needle aspirates of lymph node.
Trcić RL; Sustercić D; Kuspilić M; Jelić-Puskarić B; Fabijanić I; Kardum-Skelin I
Coll Antropol; 2010 Jun; 34(2):387-93. PubMed ID: 20698107
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetic study of 4 patients diagnosed with splenic B-cell lymphoma with villous circulating cells].
Solé F; Woessner S; Florensa L; Besses C; Palacín A; Martí M; Sans-Sabrafén J
Sangre (Barc); 1993 Aug; 38(4):335-7. PubMed ID: 8235950
[TBL] [Abstract][Full Text] [Related]
20. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
